AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
23:00
London authorities close traffic on Oxford Street: Britain’s busiest shopping street becomes pedestrian-only
22:55
Meta seeks to raise up to $95 billion to expand its artificial intelligence infrastructure
22:47
Audi CEO criticized in Germany after appearing alongside Trump / Gernot Döllner participated in the announcement of a $4.2 billion investment to build Audi’s first factory in the US
22:39
Kelemen Hunor estimates that the Luca Niculescu Government will remain in power until 2028: “If nobody brings you down, then you have no choice, you are condemned to govern”
22:33
Microsoft offers voluntary departures to approximately 60,000 employees across four countries amid massive investments in artificial intelligence
See more news